Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm

Olivier Hermine, Orianne Debeaupuis, Gandhi-Laurent Damaj, Johannes Lübke, Juliana Schwaab, Marc Heizmann, Frank Siebenhaar, Polina Pyatilova, Nicole Nojarov, Marek Niedoszytko, Aleksandra Górska, Mattias Mattsson, Khalid Shoumariyeh, Stephan de Bra, Friederike Wortmann, Nikolas von Bubnoff, Horia Bumbea, Delia Soare, Chiara Elena, Judit Varkonyi, Anna Belloni Fortina, Simge Erdem, Knut Brockow, Tobias Franz, Jens P. Panse, Deborah Christen, Christine Breynaert, Akif Selim Yavuz, Luca Malcovati, Michael Doubek, Vito Sabato, Ilaria Tanasi, Massimiliano Bonifacio, Karin Hartmann, Axel Rüfer, Mariarita Sciumè, Valentina Bellani, Irena Angelova-Fischer, Alex Stefan, Massimo Triggiani, Roberta Parente, Saskia K Klein, Michael Makris, Sotirios G. Papageorgiou, Paul van Daele, Ingunn Dybedal, Daniel Baffoe, Theo Gulen, Madlen Jentzsch, Olivier Lortholary, Maël Heiblig, Cristina Bulai Livideanu, Stéphane Barete, Clément Gourguechon, Sophie Dimicoli-Salazar, Olivier Tournilhac, Laurent Frenzel, Michel Arock, Andrzej Mital, Johannes N. Woltsche, Hanneke C. Kluin-Nelemans, Hanneke N.G. Oude Elberink, Jason Gotlib, Martina Sperr, Andreas Reiter, Peter Valent, Wolfgang R. Sperr, Julien Rossignol

Open source

DOI
10.1182/blood.2026035465
Published
2026-11-05
Container
Blood Journal
Publisher
American Society of Hematology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/blood.2026035465,
  title = {Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm},
  author = {Olivier Hermine and Orianne Debeaupuis and Gandhi-Laurent Damaj and Johannes Lübke and Juliana Schwaab and Marc Heizmann and Frank Siebenhaar and Polina Pyatilova and Nicole Nojarov and Marek Niedoszytko and Aleksandra Górska and Mattias Mattsson and Khalid Shoumariyeh and Stephan de Bra and Friederike Wortmann and Nikolas von Bubnoff and Horia Bumbea and Delia Soare and Chiara Elena and Judit Varkonyi and Anna Belloni Fortina and Simge Erdem and Knut Brockow and Tobias Franz and Jens P. Panse and Deborah Christen and Christine Breynaert and Akif Selim Yavuz and Luca Malcovati and Michael Doubek and Vito Sabato and Ilaria Tanasi and Massimiliano Bonifacio and Karin Hartmann and Axel Rüfer and Mariarita Sciumè and Valentina Bellani and Irena Angelova-Fischer and Alex Stefan and Massimo Triggiani and Roberta Parente and Saskia K Klein and Michael Makris and Sotirios G. Papageorgiou and Paul van Daele and Ingunn Dybedal and Daniel Baffoe and Theo Gulen and Madlen Jentzsch and Olivier Lortholary and Maël Heiblig and Cristina Bulai Livideanu and Stéphane Barete and Clément Gourguechon and Sophie Dimicoli-Salazar and Olivier Tournilhac and Laurent Frenzel and Michel Arock and Andrzej Mital and Johannes N. Woltsche and Hanneke C. Kluin-Nelemans and Hanneke N.G. Oude Elberink and Jason Gotlib and Martina Sperr and Andreas Reiter and Peter Valent and Wolfgang R. Sperr and Julien Rossignol},
  year = {2026},
  journal = {Blood Journal},
  doi = {10.1182/blood.2026035465},
  url = {https://doi.org/10.1182/blood.2026035465}
}

RIS

TY  - JOUR
TI  - Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm
AU  - Olivier Hermine
AU  - Orianne Debeaupuis
AU  - Gandhi-Laurent Damaj
AU  - Johannes Lübke
AU  - Juliana Schwaab
AU  - Marc Heizmann
AU  - Frank Siebenhaar
AU  - Polina Pyatilova
AU  - Nicole Nojarov
AU  - Marek Niedoszytko
AU  - Aleksandra Górska
AU  - Mattias Mattsson
AU  - Khalid Shoumariyeh
AU  - Stephan de Bra
AU  - Friederike Wortmann
AU  - Nikolas von Bubnoff
AU  - Horia Bumbea
AU  - Delia Soare
AU  - Chiara Elena
AU  - Judit Varkonyi
AU  - Anna Belloni Fortina
AU  - Simge Erdem
AU  - Knut Brockow
AU  - Tobias Franz
AU  - Jens P. Panse
AU  - Deborah Christen
AU  - Christine Breynaert
AU  - Akif Selim Yavuz
AU  - Luca Malcovati
AU  - Michael Doubek
AU  - Vito Sabato
AU  - Ilaria Tanasi
AU  - Massimiliano Bonifacio
AU  - Karin Hartmann
AU  - Axel Rüfer
AU  - Mariarita Sciumè
AU  - Valentina Bellani
AU  - Irena Angelova-Fischer
AU  - Alex Stefan
AU  - Massimo Triggiani
AU  - Roberta Parente
AU  - Saskia K Klein
AU  - Michael Makris
AU  - Sotirios G. Papageorgiou
AU  - Paul van Daele
AU  - Ingunn Dybedal
AU  - Daniel Baffoe
AU  - Theo Gulen
AU  - Madlen Jentzsch
AU  - Olivier Lortholary
AU  - Maël Heiblig
AU  - Cristina Bulai Livideanu
AU  - Stéphane Barete
AU  - Clément Gourguechon
AU  - Sophie Dimicoli-Salazar
AU  - Olivier Tournilhac
AU  - Laurent Frenzel
AU  - Michel Arock
AU  - Andrzej Mital
AU  - Johannes N. Woltsche
AU  - Hanneke C. Kluin-Nelemans
AU  - Hanneke N.G. Oude Elberink
AU  - Jason Gotlib
AU  - Martina Sperr
AU  - Andreas Reiter
AU  - Peter Valent
AU  - Wolfgang R. Sperr
AU  - Julien Rossignol
PY  - 2026
JO  - Blood Journal
DO  - 10.1182/blood.2026035465
UR  - https://doi.org/10.1182/blood.2026035465
ER  - 

APA

Hermine, O., Debeaupuis, O., Damaj, G., Lübke, J., Schwaab, J., Heizmann, M., Siebenhaar, F., Pyatilova, P., Nojarov, N., Niedoszytko, M., Górska, A., Mattsson, M., Shoumariyeh, K., Bra, S. D., Wortmann, F., Bubnoff, N. V., Bumbea, H., Soare, D., Elena, C., Varkonyi, J., Fortina, A. B., Erdem, S., Brockow, K., Franz, T., Panse, J. P., Christen, D., Breynaert, C., Yavuz, A. S., Malcovati, L., Doubek, M., Sabato, V., Tanasi, I., Bonifacio, M., Hartmann, K., Rüfer, A., Sciumè, M., Bellani, V., Angelova-Fischer, I., Stefan, A., Triggiani, M., Parente, R., Klein, S. K., Makris, M., Papageorgiou, S. G., Daele, P. V., Dybedal, I., Baffoe, D., Gulen, T., Jentzsch, M., Lortholary, O., Heiblig, M., Livideanu, C. B., Barete, S., Gourguechon, C., Dimicoli-Salazar, S., Tournilhac, O., Frenzel, L., Arock, M., Mital, A., Woltsche, J. N., Kluin-Nelemans, H. C., Elberink, H. N. O., Gotlib, J., Sperr, M., Reiter, A., Valent, P., Sperr, W. R., & Rossignol, J. (2026). Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm. Blood Journal. https://doi.org/10.1182/blood.2026035465

Source records